Confluent, Inc. SEC Filings

Confluent, Inc. (CFLT) Chief Financial Officer Sivaram Rohan reported a sale of 5,000 shares of Class A common stock on 09/08/2025 at a price of $20.00 per share. The sale was made pursuant to a 10b5-1 trading plan dated September 12, 2024. After the reported transaction, the reporting person beneficially owned 631,596 shares of Class A common stock. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Confluent, Inc. (CFLT) filed a Form 144 notifying the proposed sale of 500,000 common shares by a person holding founders shares acquired on 09/01/2014. The filing reports an aggregate market value of $10,120,000.00 and shows 291,931,187 shares outstanding, with an approximate sale date of 09/09/2025 on NASDAQ. The securities were originally issued by the company to the filer (issuer) and payment was recorded as of the acquisition date; no sales by the filer in the prior three months were reported. The filer affirms no undisclosed material adverse information and includes standard Rule 10b5-1 notice language.

Form 144 notice for Confluent, Inc. (CFLT) reports a proposed sale of 243,200 common shares with an aggregate market value of $4,922,368.00. The sale is to be executed on 09/09/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The securities were acquired and paid for on 09/09/2025 by exercise of stock options from the issuer, with payment in cash. The filing indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Form 144 notice from Confluent, Inc. (CFLT) reports a proposed sale of 1,626,667 common shares through Morgan Stanley Smith Barney LLC on NASDAQ. The filing lists an aggregate market value of $32,923,740.08 and reports total shares outstanding of 291,931,187. The shares were acquired as Founders Shares on July 21, 2020 from the issuer and no securities of the issuer were reported sold by the seller in the past three months. The notice includes the seller's representation that they are not aware of undisclosed material adverse information and indicates the filing is live.

Edward J. Kreps, who is identified as both Chief Executive Officer and a director of Confluent, Inc. (CFLT), reported same-day non-derivative transactions in the issuer's common stock on 09/04/2025. The Form 4 shows 232,500 shares of Class A common stock were acquired (transaction code C) and an equal number, 232,500 shares were sold (transaction code S) at prices reported in a range from $18.35 to $18.955 and an aggregate per-share reference of $18.66 on the form. Following the reported transactions, the filing lists 377,074 shares of Class A common stock beneficially owned directly by the reporting person. The filing also discloses multiple indirect holdings of Class A common stock held in family trusts totaling disclosed blocks of 149,984 and two 1,000,000-share holdings, and a large block of Class A shares shown as underlying Class B conversion.

Confluent, Inc. (CFLT) filed a Form 144 reporting a proposed sale of 5,000 common shares by a person for whose account the securities are to be sold. The shares were granted as restricted stock units acquired on 05/20/2024 and the seller plans to execute the sale approximately on 09/08/2025 through Morgan Stanley Smith Barney LLC. The filing reports an aggregate market value of $96,700 for the 5,000 shares and shows 291,931,187 shares outstanding.

The notice also discloses a prior sale by the same person: 26,097 common shares sold on 08/20/2025 for gross proceeds of $443,909.97. The filer affirms they have no undisclosed material adverse information and cites Rule 144/10b5-1 representations as applicable.

The Vanguard Group reports beneficial ownership of 31,019,643 shares of Confluent Inc common stock, representing 10.62% of the class. Vanguard discloses it holds 28,922,013 shares with sole dispositive power and an additional 2,097,630 shares with shared dispositive power. Voting authority is reported as 0 shares with sole voting power and 1,742,103 shares with shared voting power.

The filing states these holdings are held in the ordinary course of business on behalf of Vanguard clients, who have rights to dividends and sale proceeds, and that the securities were not acquired to change or influence control of the issuer.

Confluent, Inc. (CFLT) Form 144: This notice reports a proposed sale of 465,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $8,941,950 based on the filing. The shares represent a portion of total outstanding common shares of 291,931,187 and are scheduled for sale on 09/04/2025 on NASDAQ. The filing indicates the shares were acquired as Founders Shares on 09/27/2019 and were paid for in cash at acquisition.

The filing also discloses recent 10b5-1 sales by the same person in the past three months: 232,500 shares on 06/05/2025 (gross proceeds $5,695,203.75), 232,500 shares on 08/14/2025 (gross proceeds $3,993,675.75), and 37,707 shares on 08/20/2025 (gross proceeds $642,429.24). The notice includes the standard Rule 144 and 10b5-1 representations but provides no additional operational or financial disclosures about Confluent.

Insider sale under trading plan: Eric Vishria, a director of Confluent, Inc. (CFLT), reported an open-market sale of 30,953 shares of Class A common stock on 08/28/2025 at a reported price of $20 per share executed pursuant to a 10b5-1 trading plan adopted December 13, 2024. After the reported transaction, the filing shows beneficial ownership of 1,123,447 shares held indirectly by entities controlled by the reporting person, and an additional 20,861 shares disposed of on a separate line. The filing is a routine Section 16 Form 4 disclosure documenting the director's change in ownership and confirms the sale was pre-planned under a Rule 10b5-1 arrangement.